GlucoTrack, Inc. (GCTK) vs Regentis Biomaterials Ltd. (RGNT)

GlucoTrack, Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Regentis Biomaterials Ltd. is the larger, with a market value of $15.8M against $1.9M — 8.6× the size. Across the 7 metrics below, Regentis Biomaterials Ltd. leads on 4 and GlucoTrack, Inc. on 3.

Valuation

Metric GCTK RGNT Medical Instruments & Supplies median
P/E n/m — 34.17
P/S 2.92 — 2.83
P/B n/m n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 6.85 n/m 3.06
Earnings yield (7,562.14%) — (1.84%)
Free cash flow yield (2,683.44%) 0.00% 0.17%

Profitability

Metric GCTK RGNT Medical Instruments & Supplies median
Gross margin 0.00% — 54.62%
Operating margin 0.00% — 1.64%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 1.61%
Return on equity (620.63%) 0.00% 0.00%
Return on assets (272.48%) 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GCTK RGNT Medical Instruments & Supplies median
Revenue growth (TTM) (60.61%) — 9.20%
EPS growth (last fiscal year) 99.24% (1,504.65%) —
Revenue growth, 5-year CAGR 28.31% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GCTK RGNT Medical Instruments & Supplies median
Debt to equity (1.11) 0.00 0.08
Current ratio 0.46 5.62 2.49
Net debt to EBITDA 0.25 0.89 0.83

Dividend

Metric GCTK RGNT Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric GCTK RGNT Medical Instruments & Supplies median
Market cap 1.85m 15.82m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack